Page last updated: 2024-10-21

acebutolol and Arrhythmogenic Right Ventricular Cardiomyopathy

acebutolol has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research Excerpts

ExcerptRelevanceReference
"A 29-year-old primigravida, diagnosed with ARVD 1 year prior to pregnancy, underwent a full-term, uncomplicated pregnancy and delivery while maintained on acebutolol and an implanted cardioverter defibrillator."3.73Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. ( Bathgate, SL; Lee, LC; Macri, CJ, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, LC1
Bathgate, SL1
Macri, CJ1

Other Studies

1 other study available for acebutolol and Arrhythmogenic Right Ventricular Cardiomyopathy

ArticleYear
Arrhythmogenic right ventricular dysplasia in pregnancy: a case report.
    The Journal of reproductive medicine, 2006, Volume: 51, Issue:9

    Topics: Acebutolol; Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Combined Moda

2006